Precision Therapy Versus Standard Therapy in AML and MDS in Elderly
Precision Therapy Versus Standard Therapy in AML and MDS in Elderly
Recruiting · NCT05025098 · Registry updated 2021-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Precision Therapy Versus Standard Therapy in AML and MDS in Elderly | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2021-08-27 | NCT05025098 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital, Akershus | 87 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akershus Universitetssykehus | Lørenskog | Norway | 2 |